Bill Melville Bill Melville

Bill Melville is a Principal Analyst for DRG. He is a national expert on health insurance exchanges and Medicare. He can be reached on Twitter at @BillMelvilleDRG.

Is Step Therapy Now a Possibility for Part B Drugs?

The Trump administration’s drug cost blueprint looked at the possibility of moving Part B ...